The not-for-profit form and translational research: Kerr revisited?

Journal of Translational Medicine

Volumn 3, Issue , 2005, Pages

  Joiner, Keith A ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDGET; CONTINUING EDUCATION; COST BENEFIT ANALYSIS; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CENTER; HEALTH PROMOTION; HUMAN; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; OUTCOMES RESEARCH; PROFESSIONAL PRACTICE; QUALITY CONTROL;

EID: 27344439104     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-3-19     Document Type: Article

References (22)

1. Kerr S: An Academy Classic On the folly of rewarding A while hoping for B. Academy of Management Executive 1995, 9:.
2. Parks MR, Disis ML: Conflicts of interest in translational research. J Transl Med 2004, 2:28.
3. Oster SM: Strategic Management for Nonprofit Organizations Theory and Cases., Oxford University Press; 1995.
4. Hansmann HB: The role of nonprofit enterprise. The Yale Law Journal 1980, 89:835-898.
5. Unterman I, Davis R: Strategic Management of Not-For-Profit Organizations. New York,; 1984.
6. Salamon LM: America's Non-Profit Sector. A Primer. New York, The Foundation Center, 1992.
7. Ott JS: The Nature of the Nonprofit Sector., Westview Press; 2000.
8. Goldstein JL, Brown MS: The clinical Investigator: Bewitched, bothered, and bewildered-but still beloved. J Clin Invest 1997, 99:2803-2812.
9. Kotchen TA, Lindquist T, Malik K, Ehrenfeld E. NIH peer review of grant applications for clinical research. Jama 2004, 291:836-843.
10. Williams GH, Wara DW, Carbone P: Funding for patient-oriented research. Critical strain on a fundamental linchpin. JAMA 1997, 278:227-231.
11. Sung NS, Crowley WFJ, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D: Central challenges facing the national clinical research enterprise. Jama 2003, 289:1278-1287.
12. Snyderman R: The clinical researcher-an "emerging" species. Jama 2004, 291:882-883.
13. Crowley WFJ, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, Genel M, Korn A, Reame N, Bonow R. Grebb J, Rimoin D: Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. Jama 2004, 291:1120-1126.
14. Stokes DE: Pasteur's Quadrant. Basic Science and Technological Innovation. Washington, D.C., The Brookings Institution; 1997.
15. Gross CP, Anderson GF, Powe NR: The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999, 340:1881-1887.
16. Varmus H: Evaluating the burden of disease and spending the research dollars of the National Institutes of Health. N Engl J Med 1999, 340:1914-1915.
17. IOM: Scientific opportunities and public needs: improving the priority setting and publich input at the National Institutes of Health. Washington, D.C., Institute of Medicine; National Academy Press; 1998.
18. Martin J: Research in biomedicine. Is anyone representing/advocating the public interest? Eur J Public Health 2001, 11:458-459.
19. Brown LP, Bair AH, Meier PP: Does federal funding for breastfeeding research target our national health objectives? Pediatrics 2003, 111:e360-4.
20. Levinsky NG: Nonfinancial conflicts of interest in research. N Engl J Med 2002, 347:759-761.
21. von Schroeder HP: The altruistic medical researcher: gone and forgotten? Ann R Coll Physicians Surg Can 1997, 30:353-358.
22. Facilitating Interdisciplinary Research, Edited by: national Academy of Sciences NAEIM. Washington, D.C., National Academies Press; 2005.